会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • COLOR TEMPERATURE CONTROL OF FLASH UNITS
    • 闪光灯的颜色温度控制
    • US20120112658A1
    • 2012-05-10
    • US12676980
    • 2008-09-09
    • Hans-Peter HauserMarcel GriessmannMartin BuserUrs Zeltner
    • Hans-Peter HauserMarcel GriessmannMartin BuserUrs Zeltner
    • H05B37/02
    • A flash unit (1) with a flash generator (20) with at least one energy store (21) and at least two luminaire channels and with at least two flash tubes (11, 12, 13), wherein the flash tubes (11, 12, 13) are supplied with energy by the energy store (21) via the luminaire channels, with an energy quantity control apparatus (14), by means of which any desired quantity of energy from the minimum charge up to the maximum charge of the at least one energy store (21) can be provided for each luminaire channel, and with a colour temperature control apparatus (15), by means of which a coloured temperature can be set for each luminaire channel independently of the quantity of energy provided therefor, and a corresponding method therefor.
    • 一种具有闪光发生器(20)的闪光单元(1),具有至少一个能量存储器(21)和至少两个照明器通道以及至少两个闪光管(11,12,13),其中闪光灯管(11, 12)由能量储存器(21)通过灯具通道与能量控制装置(14)一起被供能,通过该能量控制装置,从最小充电到最大充电的任何所需量的能量 可以为每个灯具通道提供至少一个能量存储器(21),并且可以使用色温控制设备(15),通过该色温控制设备可以独立于为其提供的能量的量而为每个灯具通道设置着色温度, 及其相应的方法。
    • 2. 发明申请
    • Albumin-Fused Anti-Angiogenesis Peptides
    • 白蛋白融合抗血管生成肽
    • US20090175893A1
    • 2009-07-09
    • US12358815
    • 2009-01-23
    • Peter MertinsIlhan CelikOliver KiskerDarrell SleepJoanna HayHans-Peter Hauser
    • Peter MertinsIlhan CelikOliver KiskerDarrell SleepJoanna HayHans-Peter Hauser
    • A61K39/00A61K38/16
    • A61K38/39A01K2217/05A61K9/0019A61K31/7088A61K38/00A61K39/00A61K39/0005A61K47/643A61K48/00A61K2039/53C07K14/005C07K14/47C07K14/765C07K14/78C07K14/8114C07K2319/00C07K2319/31C12N15/62C12N2740/16122C12Y301/26003
    • The invention relates to proteins comprising angiogenesis inhibiting peptides, such as endostatin peptides (including, but not limited to, fragments and variants thereof), which exhibit anti-retroviral activity, fused or conjugated to albumin (including, but not limited to fragments or variants of albumin). These fusion proteins are herein collectively referred to as “albumin fusion proteins of the invention.” These fusion proteins are herein collectively referred to as “albumin fusion proteins of the invention.” These fusion proteins exhibit extended shelf-life and/or extended or therapeutic activity in solution. The invention encompasses therapeutic albumin fusion proteins, compositions, pharmaceutical compositions, formulations and kits. The invention also encompasses nucleic acid molecules encoding the albumin fusion proteins of the invention, as well as vectors containing these nucleic acids, host cells transformed with these nucleic acids and vectors, and methods of making the albumin fusion proteins of the invention using these nucleic acids, vectors, and/or host cells. The invention also relates to compositions and methods for inhibiting proliferation of vascular endothelial cells and tumor angiogenesis induced cell fusion. The invention further relates to compositions and methods preventing growth of, or promoting regression of, primary tumors and metastases; and for treating cancer, diabetic retinopathy, progressive macular degeneration or rheumatoid arthritis.
    • 本发明涉及包含血管生成抑制肽(例如内皮抑素肽(包括但不限于其片段和变体))的蛋白质,其表现出与白蛋白融合或缀合的抗逆转录病毒活性(包括但不限于片段或变体 的白蛋白)。 这些融合蛋白在本文中统称为“本发明的白蛋白融合蛋白”。 这些融合蛋白在本文中统称为“本发明的白蛋白融合蛋白”。 这些融合蛋白在溶液中表现出延长的保质期和/或延长或治疗活性。 本发明包括治疗性白蛋白融合蛋白,组合物,药物组合物,制剂和试剂盒。 本发明还包括编码本发明的白蛋白融合蛋白的核酸分子以及含有这些核酸的载体,用这些核酸和载体转化的宿主细胞,以及使用这些核酸制备本发明的白蛋白融合蛋白的方法 ,载体和/或宿主细胞。 本发明还涉及抑制血管内皮细胞增殖和肿瘤血管生成诱导的细胞融合的组合物和方法。 本发明还涉及预防原发性肿瘤和转移瘤的生长或促进消退的组合物和方法; 并用于治疗癌症,糖尿病性视网膜病变,进行性黄斑变性或类风湿性关节炎。
    • 3. 发明申请
    • Albumin-Fused Kunitz Domain Peptides
    • 白蛋白融合Kunitz结构域肽
    • US20080274969A1
    • 2008-11-06
    • US12114477
    • 2008-05-02
    • Hans-Peter HauserThomas WeimerVal RombergScott M. KeeDarrell SleepRobert Charles LadnerArthur C. Ley
    • Hans-Peter HauserThomas WeimerVal RombergScott M. KeeDarrell SleepRobert Charles LadnerArthur C. Ley
    • A61K38/38C07K14/76C07H21/00C12N15/00C12N5/00C12P21/04
    • C12N15/62C07K2319/31
    • The invention relates to proteins comprising serine protease inhibiting peptides, such as Kunitz domain peptides (including, but not limited to, fragments and variants thereof) fused to albumin, or fragments or variants thereof. These fusion proteins are herein collectively referred to as “albumin fusion proteins of the invention.” These fusion proteins exhibit extended shelf-life and/or extended or therapeutic activity in solution. The invention encompasses therapeutic albumin fusion proteins, compositions, pharmaceutical compositions, formulations and kits. The invention also encompasses nucleic acid molecules and vectors encoding the albumin fusion proteins of the invention, host cells transformed with these nucleic acids and vectors, and methods of making the albumin fusion proteins of the invention using these nucleic acids, vectors, and/or host cells. The invention also relates to compositions and methods for inhibiting neutrophil elastase, kallikrein, and plasmin. The invention further relates to compositions and methods for treating cystic fibrosis and cancer.
    • 本发明涉及包含丝氨酸蛋白酶抑制肽的蛋白质,例如与白蛋白或其片段或变体融合的Kunitz结构域肽(包括但不限于其片段和变体)。 这些融合蛋白在本文中统称为“本发明的白蛋白融合蛋白”。 这些融合蛋白在溶液中表现出延长的保质期和/或延长或治疗活性。 本发明包括治疗性白蛋白融合蛋白,组合物,药物组合物,制剂和试剂盒。 本发明还包括编码本发明的白蛋白融合蛋白,用这些核酸和载体转化的宿主细胞的核酸分子和载体,以及使用这些核酸,载体和/或宿主制备本发明的白蛋白融合蛋白的方法 细胞。 本发明还涉及抑制嗜中性粒细胞弹性蛋白酶,激肽释放酶和纤溶酶的组合物和方法。 本发明还涉及治疗囊性纤维化和癌症的组合物和方法。